Home

freedom highlight Ruin kappa opioid receptor agonist amusement kitten boy

Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal  of Neuroscience
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and  its roles in human therapeutics - ScienceDirect
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect

Structure of the human κ-opioid receptor in complex with JDTic | Nature
Structure of the human κ-opioid receptor in complex with JDTic | Nature

Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes  for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry

Opioids in cancer: The κ‑opioid receptor (Review)
Opioids in cancer: The κ‑opioid receptor (Review)

Molecular mechanism of biased signaling at the kappa opioid receptor |  Nature Communications
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications

Down-regulation of kappa opioid receptor promotes ESCC proliferation,  invasion and metastasis via the PDK1-AKT signaling pathway | Cell  Communication and Signaling | Full Text
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text

The blocking of kappa‐opioid receptor reverses the changes in dorsolateral  striatum dopamine dynamics during the amphetamine sensitization - Azocar -  2019 - Journal of Neurochemistry - Wiley Online Library
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library

Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for  the Development of Potential Treatments of Pain with Reduced Side Effects
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and  Back
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back

Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role -  ScienceDirect
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect

A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New  Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse |  Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage

Table II from Systemic kappa opioid receptor agonists in the treatment of  chronic pruritus: a literature review. | Semantic Scholar
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar

Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid  Agonists
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists

Topical administration of the kappa opioid receptor agonist nalfurafine  suppresses corneal neovascularization and inflammation | Scientific Reports
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports

μ-Opposing actions of the κ-opioid receptor: Trends in Pharmacological  Sciences
μ-Opposing actions of the κ-opioid receptor: Trends in Pharmacological Sciences

Kinase cascades and ligand-directed signaling at the kappa opioid receptor  | SpringerLink
Kinase cascades and ligand-directed signaling at the kappa opioid receptor | SpringerLink

Representative examples of common scaffolds in kappa opioid receptor... |  Download Scientific Diagram
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram

Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for  the Development of Potential Treatments of Pain with Reduced Side Effects
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

Nephrology Journal Club on Twitter: "Difelikefalin (CR845) (KORSUVA) is a  peripherally restricted, selective kappa opioid receptor agonist that  exerts antipruritic effects by means of activation of kappa opioid receptors  on peripheral neurons
Nephrology Journal Club on Twitter: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons

Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands:  Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience

Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse |  National Institute on Drug Abuse (NIDA)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)

Constitutive activation of kappa opioid receptors at ventral tegmental area  inhibitory synapses following acute stress | eLife
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife

Development of κ opioid receptor antagonists. | Semantic Scholar
Development of κ opioid receptor antagonists. | Semantic Scholar

Biased agonists of the kappa opioid receptor suppress pain and itch without  causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling

Frontiers | A Review of the Therapeutic Potential of Recently Developed G  Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists